Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients

Inclusion Criteria: 1. AIS patients with anterior circulation due to large vessel occlusion; 2. Age between 18 and 80 years; 3. Baseline NIHSS score ≥ 6; 4 .Successful recanalization after thrombectomy (mTICI grade ≥ 2b); 5. Written informed consent provided by the patients or their legal relatives. . Exclusion Criteria: Upon admission, the patient's medical history and physical examination revealed manifestations indicative of congestive heart failure (CHF), such as jugular venous distention, the presence of a third heart sound, resting tachycardia at a rate of 100 beats per minute attributable to heart failure, hepatomegaly, and/or lower extremity edema attributable to heart failure or of unknown etiology; History of acute myocardial infarction within the preceding 3 months; The patient's medical history, electrocardiogram findings upon admission, or physical examination indicated the presence of second- or third-degree heart block or any arrhythmia associated with hemodynamic instability, as determined by the investigator's assessment; Acute or chronic renal failure with serum creatinine levels exceeding 2.0 mg/dL; Severe anemia characterized by a hematocrit below 32%; Computed tomography findings upon admission indicating the presence of any form of hemorrhage; Pregnancy status; Previous history of allergic reactions to albumin administration; Elevated blood pressure exceeding 185/110 mmHg when investigating the use of albumin administration; Presence of other potentially life-threatening medical conditions; Individuals with current chronic lung diseases, such as chronic obstructive pulmonary disease, bronchiectasis, or any other lung disorder that significantly impairs daily activities; 12. Individuals with known allergies to albumin.